Latest Pharmaceuticals News
FDA Grants Priority Review of Biologics License Application for Dupixent Add-on Maintenance for Treatment of Youth with Chronic Rhinosinusitis with Nasal Polyposis
Dupixent was previously approved for adults with chronic sinusitis with poorly controlled…
Aardvark Therapeutics completes over $85 million in Series C funding to advance ARD-101 in the treatment of bulimia in patients with Prader-Willi syndrome
The latest funding round, led by Decheng Capital, also included participation from…
Biosimilars roadmap: understanding payer perceptions
With competition for biosimilars intensifying and a potential market boom perhaps just…
Pharma Pulse 5/13/24: Community Pharmacy’s Role in Social Determinants of Health, A Year in Ozempic…What We Think We’re All Wrong About Obesity, and More
The latest news for those in the pharmaceutical industry.
Study shows potential of psilocybin as an antidepressant compared to non-psychoactive drugs
Study results showed that psilocybin may reduce symptoms of depression, with significant…
7 essential attributes for investing in life sciences
These factors provide investors with sufficient information to identify promising investment opportunities.
